Literature DB >> 9862249

Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve.

D Annane1, E Bellissant, V Sebille, O Lesieur, B Mathieu, J C Raphael, P Gajdos.   

Abstract

AIMS: To investigate the relationship between adrenal gland function and pressor response to noradrenaline in septic shock.
METHODS: Basal cortisol level, noradrenaline--mean arterial pressure dose-response curve and cortisol response to intravenous corticotrophin bolus were obtained in nine patients fulfilling usual criteria for septic shock and in six normal volunteers. In patients with septic shock, dose-response curve to noradrenaline was determined a second time 60 min after a 50 mg intravenous hydrocortisone bolus.
RESULTS: As compared with controls, patients with septic shock had increased basal cortisol levels (mean+/-s.d.: 1564+/-818 vs 378+/-104 nmol l(-1) , P=0.002, 95% confidence interval for difference in means: [452, 1920]) and a blunted cortisol response to corticotrophin (403+/-461 vs 1132+/-195 nmol l(-1), P=0.008, [-1163, -2951). Five patients had impaired adrenal function reserve. As compared with controls, septic patients displayed a moderate and non significant decrease in pressor sensitivity to noradrenaline (P=0.112). As compared with patients with adequate adrenal response, patients with impaired adrenal function reserve showed a significant decrease in pressor sensitivity to noradrenaline (P=0.038). In septic patients, hydrocortisone improved pressor response to noradrenaline (P=0.032). This effect was more marked in patients with impaired adrenal function reserve so that, as compared with patients with adequate response, the difference was no longer significant (P=0.123).
CONCLUSIONS: In septic shock, impaired adrenal function reserve may partly be accounted for by the depressed pressor sensitivity to noradrenaline. The latter may be substantially improved by physiological doses of hydrocortisone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862249      PMCID: PMC1873798          DOI: 10.1046/j.1365-2125.1998.00833.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  35 in total

1.  Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections.

Authors:  W J Sibbald; A Short; M P Cohen; R F Wilson
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

2.  Reversal of late septic shock with supraphysiologic doses of hydrocortisone.

Authors:  P E Bollaert; C Charpentier; B Levy; M Debouverie; G Audibert; A Larcan
Journal:  Crit Care Med       Date:  1998-04       Impact factor: 7.598

3.  Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines.

Authors:  J R Parratt
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

4.  A direct determination of plasma aldosterone.

Authors:  M T Pham-Huu-Trung; P Corvol
Journal:  Steroids       Date:  1974-11       Impact factor: 2.668

5.  Cortisol replacement in severely stressed patients.

Authors:  J I McKee; W E Finlay
Journal:  Lancet       Date:  1983-02-26       Impact factor: 79.321

Review 6.  Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations.

Authors:  H J Motulsky; P A Insel
Journal:  N Engl J Med       Date:  1982-07-01       Impact factor: 91.245

Review 7.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

8.  Peripheral vascular adrenergic depression during hypotension induced by E coli endotoxin.

Authors:  R F Bond
Journal:  Adv Shock Res       Date:  1983

9.  Assay of plasma catecholamines by liquid chromatography with electrochemical detection.

Authors:  R C Causon; M E Carruthers; R Rodnight
Journal:  Anal Biochem       Date:  1981-09-01       Impact factor: 3.365

10.  The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study.

Authors:  C L Sprung; P V Caralis; E H Marcial; M Pierce; M A Gelbard; W M Long; R C Duncan; M D Tendler; M Karpf
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

View more
  53 in total

Review 1.  Hydrocortisone and the reduction of vasopressors in septic shock: therapy or only chart cosmetics?

Authors:  J Briegel
Journal:  Intensive Care Med       Date:  2000-12       Impact factor: 17.440

2.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Neal H. Steigbigel
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

3.  Low doses of fludrocortisone and hydrocortisone, alone or in combination, on vascular responsiveness to phenylephrine in healthy volunteers.

Authors:  Bruno Laviolle; Erwan Donal; Pascale Le Maguet; Fabrice Lainé; Eric Bellissant
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 4.  Adrenal insufficiency: etiology, diagnosis and treatment.

Authors:  Nicola Neary; Lynnette Nieman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

5.  Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy.

Authors:  Jerome Morel; Christophe Venet; Yannis Donati; David Charier; Jerome Liotier; Delphine Frere-Meunier; Stephane Guyomarc'h; Eric Diconne; Jean Claude Bertrand; Bertrand Souweine; Laurent Papazian; Fabrice Zeni
Journal:  Intensive Care Med       Date:  2006-06-20       Impact factor: 17.440

Review 6.  Update on adrenal insufficiency in patients with liver cirrhosis.

Authors:  Anca Trifan; Stefan Chiriac; Carol Stanciu
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

7.  Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis.

Authors:  Yan Li; Xizhong Cui; Xuemei Li; Steven B Solomon; Robert L Danner; Steven M Banks; Yvonne Fitz; Djillali Annane; Charles Natanson; Peter Q Eichacker
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

8.  Critical illness-related corticosteroid insufficiency in patients with severe acute biliary pancreatitis: a prospective cohort study.

Authors:  Yun-Shing Peng; Cheng-Shyong Wu; Yung-Chang Chen; Jau-Min Lien; Ya-Chung Tian; Ji-Tseng Fang; Chun Yang; Yun-Yi Chu; Chien-Fu Hung; Chih-Wei Yang; Pang-Chi Chen; Ming-Hung Tsai
Journal:  Crit Care       Date:  2009-07-24       Impact factor: 9.097

9.  CORTICUS: the end of unconditional love for steroid use?

Authors:  Phillip E Mason; Ali Al-Khafaji; Eric B Milbrandt; Brian P Suffoletto; David T Huang
Journal:  Crit Care       Date:  2009-08-07       Impact factor: 9.097

10.  A prospective study on the incidence and predictive factors of relative adrenal insufficiency in Korean critically-ill patients.

Authors:  Yong Soo Kwon; Eunhae Kang; Gee Young Suh; Won-Jung Koh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Jae Hoon Chung
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.